Salt Creek Medical
Salt Creek Medical Device Development is a medical device company incubator with an integrated Venture Fund structured to create new companies to advance clinical medical care. This generator was founded by two experienced medical device professionals who know how to start companies from the "ground up" and have a history of multiple successful company exits.

The Salt Creek Difference - the Integration of Skills and Capital for Success:
  • A seasoned team of medical device entrepreneurs with over 80 years of combined healthcare experience
  • A permanent facility with prototyping and manufacturing capabilities to support research, development, pilot and clinical scale production runs
  • FDA/ISO Compliant Quality System to ensure the highest level of regulatory compliance
  • Ability to prepare and manage clinical studies and regulatory submissions across the globe
  • CAPITAL through an integrated financing arm - Salt Creek Fund I

Salt Creek Medical was started in 2006 by Fred Burbank, M.D. and Mike Jones. This experienced team started, developed, and completed the sale of Vascular Control Systems, Inc. (San Juan Capistrano) to Ethicon, Inc., a Johnson & Johnson Company, in May 2006. Dr. Burbank is also the previous founder and principal inventor of the technologies developed and commercialized by Biopsys (acquired by Ethicon Endo-Surgery, Inc., a Johnson & Johnson Company in 1997) and SenoRx (acquired by C.R. Bard, Inc. in 2010). As a medical device company incubator, Salt Creek Medical has the core operating skills to develop early stage companies as well as the tactical leadership to drive each to a successful exit process.

Companies Formed
Salt Creek Fund I Finances Five Series-A Medical Device Start-Up Companies
To minimize time-loss when performing round-by-round fund raising for five to six separate companies, Salt Creek Medical and its investors developed the Salt Creek Fund I. Among others, the investors in Salt Creek Fund I include Shea Ventures and Johnson & Johnson Development Corporation. Since the first closing in December of 2007, Salt Creek Fund I has financed five Series-A medical device start-ups:

Mariposa Biotechnology, Inc. (established in 2008) has developed a proprietary laboratory instrument that automates time-sensitive, labor-intensive steps in an IVF Laboratory. Our instruments prepare embryos and eggs for freezing and thawing.

Sensory Medical, Inc. (established in 2008) has developed medical devices for the non-drug treatment of Restless Legs Syndrome (RLS). Prevalence studies estimate that 5-10% of the population suffers from RLS, a condition that causes significant discomfort and adversely affects the quality of life of patients by interrupting sleep.

Nasolex, Inc. (established in 2009) is creating an alternative to continuous positive airway pressure (CPAP) therapy for the treatment of obstructive sleep apnea (OSA).

Reset Medical, Inc. (established in 2012) is developing a simple surgical tool (similar to a suture applier) for transvaginal uterine artery ligation.

ECD Medical, Inc. (established in 2012) is developing a new arterial closure device for the large arterial punctures encountered in transvascular procedures such as abdominal aortic aneurysm repair and heart valve replacements.
Salt Creek Medical Device Development
1235 Puerta del Sol #700
San Clemente, CA 92673